GC Labs

GC Labs, established in 1967, operates as a specialized clinical testing institution focused on advancing healthcare through diagnostic innovation. The organization provides a comprehensive suite of clinical laboratory services, including allergy antigen testing and complex disease-related examinations. By leveraging advanced diagnostic equipment and professional research personnel, GC Labs supports healthcare providers and researchers in achieving precise clinical outcomes. The company maintains a strong commitment to public health, contributing to the well-being of citizens through rigorous testing protocols and specialized laboratory methodologies.

The company maintains a robust operational footprint with 500-1,000 employees dedicated to clinical excellence. Operating from a single primary facility located in Giheung-gu Yongin-si, South Korea, GC Labs integrates innovative research with high-throughput diagnostic capabilities. This centralized laboratory model ensures consistent quality control and rapid turnaround times for critical medical diagnostics. The institution serves as a vital partner for clinical research initiatives, providing the technical infrastructure necessary for large-scale disease studies and international health collaborations.

GC Labs continues to expand its influence within the Asia-Pacific healthcare sector by fostering international partnerships focused on infectious disease research. The organization’s strategic focus on B2B diagnostic services and clinical research support positions it as a key player in the regional medical testing landscape. Meet GC Labs's team to learn more about the professional personnel driving these diagnostic advancements. Through its long-standing history and commitment to medical science, GC Labs remains a cornerstone of clinical diagnostic reliability and innovation in the global healthcare market.